153 related articles for article (PubMed ID: 21428867)
1. Non-invasive iontophoretic delivery of peptides and proteins across the skin.
Gratieri T; Kalaria D; Kalia YN
Expert Opin Drug Deliv; 2011 May; 8(5):645-63. PubMed ID: 21428867
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins.
Dubey S; Kalia YN
J Control Release; 2010 Aug; 145(3):203-9. PubMed ID: 20423719
[TBL] [Abstract][Full Text] [Related]
3. Iontophoretic drug delivery.
Kalia YN; Naik A; Garrison J; Guy RH
Adv Drug Deliv Rev; 2004 Mar; 56(5):619-58. PubMed ID: 15019750
[TBL] [Abstract][Full Text] [Related]
4. Iontophoresis-based transdermal delivery systems.
Kanikkannan N
BioDrugs; 2002; 16(5):339-47. PubMed ID: 12408738
[TBL] [Abstract][Full Text] [Related]
5. Structure-permeation relationships for the non-invasive transdermal delivery of cationic peptides by iontophoresis.
Schuetz YB; Carrupt PA; Naik A; Guy RH; Kalia YN
Eur J Pharm Sci; 2006 Sep; 29(1):53-9. PubMed ID: 16837178
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous delivery of proteins and peptides using iontophoretic techniques.
Parasrampuria D; Parasrampuria J
J Clin Pharm Ther; 1991 Feb; 16(1):7-17. PubMed ID: 2026670
[TBL] [Abstract][Full Text] [Related]
7. Transcending the skin barrier to deliver peptides and proteins using active technologies.
Singh N; Kalluri H; Herwadkar A; Badkar A; Banga AK
Crit Rev Ther Drug Carrier Syst; 2012; 29(4):265-98. PubMed ID: 22746186
[TBL] [Abstract][Full Text] [Related]
8. Electrically-assisted delivery of an anionic protein across intact skin: cathodal iontophoresis of biologically active ribonuclease T1.
Dubey S; Kalia YN
J Control Release; 2011 Jun; 152(3):356-62. PubMed ID: 21397646
[TBL] [Abstract][Full Text] [Related]
9. Transdermal therapy and diagnosis by iontophoresis.
Merino V; Kalia YN; Guy RH
Trends Biotechnol; 1997 Aug; 15(8):288-90. PubMed ID: 9263476
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and therapeutic applications of iontophoresis.
Sieg A; Wascotte V
J Drug Target; 2009 Nov; 17(9):690-700. PubMed ID: 19845485
[TBL] [Abstract][Full Text] [Related]
11. Mathematical models to describe iontophoretic transport in vitro and in vivo and the effect of current application on the skin barrier.
Gratieri T; Kalia YN
Adv Drug Deliv Rev; 2013 Feb; 65(2):315-29. PubMed ID: 22626977
[TBL] [Abstract][Full Text] [Related]
12. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
[TBL] [Abstract][Full Text] [Related]
13. Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: effect of experimental conditions and a comparison with other enhancement strategies.
Cázares-Delgadillo J; Ganem-Rondero A; Quintanar-Guerrero D; López-Castellano AC; Merino V; Kalia YN
Eur J Pharm Sci; 2010 Mar; 39(5):387-93. PubMed ID: 20096354
[TBL] [Abstract][Full Text] [Related]
14. Microneedle assisted iontophoretic transdermal delivery of prochlorperazine edisylate.
Kolli CS; Xiao J; Parsons DL; Babu RJ
Drug Dev Ind Pharm; 2012 May; 38(5):571-6. PubMed ID: 21980925
[TBL] [Abstract][Full Text] [Related]
15. Transdermal iontophoresis of insulin: III. Influence of electronic parameters.
Pillai O; Kumar N; Dey CS; Borkute ; Sivaprasad N; Panchagnula R
Methods Find Exp Clin Pharmacol; 2004; 26(6):399-408. PubMed ID: 15349135
[TBL] [Abstract][Full Text] [Related]
16. Transdermal iontophoresis. Part II: Peptide and protein delivery.
Pillai O; Nair V; Poduri R; Panchagnula R
Methods Find Exp Clin Pharmacol; 1999 Apr; 21(3):229-40. PubMed ID: 10389126
[TBL] [Abstract][Full Text] [Related]
17. AC electrokinetic platform for iontophoretic transdermal drug delivery.
Lvovich VF; Matthews E; Riga AT; Kaza L
J Control Release; 2010 Jul; 145(2):134-40. PubMed ID: 20420867
[TBL] [Abstract][Full Text] [Related]
18. Effect of amino acid sequence on transdermal iontophoretic peptide delivery.
Schuetz YB; Naik A; Guy RH; Kalia YN
Eur J Pharm Sci; 2005 Dec; 26(5):429-37. PubMed ID: 16143501
[TBL] [Abstract][Full Text] [Related]
19. [Enhancement of drug absorption by iontophoresis and phonophoresis and clinical application].
Yata N
Nihon Rinsho; 1998 Mar; 56(3):608-12. PubMed ID: 9549344
[TBL] [Abstract][Full Text] [Related]
20. A novel method to enhance the efficiency of drug transdermal iontophoresis delivery by using complexes of drug and ion-exchange fibers.
Xin C; Li-hong W; Yue Y; Ya-nan G; Qi-fang W; Yang Y; San-ming L
Int J Pharm; 2012 May; 428(1-2):68-75. PubMed ID: 22405965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
